Literature DB >> 2676058

Effects of pinacidil on the sympatho-adrenal system in dogs.

C Damase-Michel1, M A Tran, J L Montastruc, J P Moatti, P Montastruc.   

Abstract

1. The aim of the present work was to study the antihypertensive effect of pinacidil, a potassium channel opener, in sinoaortic denervated (SAD) conscious dogs and to investigate whether the involvement of the sympathetic nervous system induced by this vasodilator compound is only of baroceptor reflex origin. 2. Pinacidil (0.1, 0.2, 0.4 mg kg-1 i.v.) induced a dose-dependent decrease in blood pressure in normal as well as in SAD dogs. In contrast, the induced-tachycardia observed in normal dogs was not found in SAD animals. 3. Since pinacidil induced an increase in plasma catecholamines, free fatty acids, glucose, plasma renin activity and aldosterone in SAD dogs it is suggested that this sympathetic activation is independent of the baroreceptor reflex pathways. 4. The sympathetic activation is mainly of peripheral origin, since pinacidil (0.7 mg kg-1 i.v.) induced an increase in adrenaline release from the adrenal gland after section of the great splanchnic nerve in anaesthetized dogs. This increase is probably due to an effect that does not involve K+ channel opening. However, this effect of pinacidil was not observed during splanchnic nerve stimulation (in this case, the involvement of K+ channel opening is suggested).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676058      PMCID: PMC1854629          DOI: 10.1111/j.1476-5381.1989.tb12557.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  [The alpha, beta adrenolytic effect on catecholaminergic mobilization of the plasma free fatty acids in the intact and the adrenalectomized dog].

Authors:  M Berlan
Journal:  Arch Farmacol Toxicol       Date:  1976-08

2.  Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.

Authors:  S Kawashima; C S Liang
Journal:  J Pharmacol Exp Ther       Date:  1985-02       Impact factor: 4.030

3.  Effects of the adrenergic agonists isoprenaline and noradrenaline and the alpha-blocking agents dihydroergotamine and phentolamine on the lipolysis in isolated fat cells of the rat, guinea pig, dog and man.

Authors:  M Milavec-Krizman; H Wagner
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

4.  [Differences between tyramine and dimethylphenylpiperazine in the Ca++-dependency and in the temporary course of noradrenaline release from the isolated rabbit heart].

Authors:  R Lindmar; K Löffelholz; E Muscholl
Journal:  Experientia       Date:  1967-11-15

5.  Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.

Authors:  J W Ward; A McBurney; P R Farrow; P Sharp
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator.

Authors:  E Arrigoni-Martelli; C K Nielsen; U B Olsen; H J Petersen
Journal:  Experientia       Date:  1980-04-15

7.  Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.

Authors:  J E Carlsen; T Kardel; T Hilden; M Tangø; J Trap-Jensen
Journal:  Clin Physiol       Date:  1981-08

8.  Pinacidil monotherapy for hypertension.

Authors:  J W Ward
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

9.  The effect of diltiazem on noradrenaline release.

Authors:  C Wolchinsky; T T Zsotér
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

10.  Adrenal catecholamine output in response to stimulation of the splanchnic nerve in bursts in the conscious calf.

Authors:  A V Edwards
Journal:  J Physiol       Date:  1982-06       Impact factor: 5.182

View more
  2 in total

Review 1.  Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H A Friedel; R N Brogden
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

2.  Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.

Authors:  A Chu; D E Chambers; C C Lin; W D Kuehl; R M Palmer; S Moncada; F R Cobb
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.